v3.24.0.1
STOCKHOLDERS' EQUITY (Tables)
 12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Summary of Stock Option Activity
A summary of stock option activity for the year ended December 31, 2023 is as follows (in thousands, except share and per share data):
Number of Stock Options OutstandingWeighted
Average
Exercise
Price		Weighted
Average
Remaining
Contractual
Term
(in years)		Aggregate
Intrinsic
Value
Outstanding, beginning of the period6,739 $40.37 4.02$224,484 
Granted682 65.16 
Exercised(2,065)21.38 
Forfeited(311)95.32 
Expired(54)91.69 
Outstanding, end of the period4,991 $47.64 3.80$195,760 
Exercisable, end of the period4,250 $40.26 2.94$189,357 
Restricted Stock Awards and Restricted Stock Units Activity
Activity related to RSAs and RSUs during the year ended December 31, 2023 is set forth below:
Number of
Shares		Weighted
Average Grant
Date Fair Value
Unvested, beginning of the period28,300 $97.89 
Granted30,233 61.03 
Vested(14,211)86.84 
Forfeited(4,223)90.82 
Unvested, end of the period40,099 $74.76 
Fair Value Assumptions for Options
The fair values of stock options granted were estimated using the following weighted-average assumptions:
Year Ended December 31,
202320222021
Dividend yield— %— %— %
Risk-free interest rate3.48 %3.08 %1.08 %
Expected volatility62.32 %59.2 %54.91 %
Expected term (years)6.026.026.02
Summary of the Effect of Share-Based Compensation on the Consolidated Statements of Operations
The following table summarizes the effects of share-based compensation on the consolidated statements of operations (in thousands):
Year Ended December 31,
202320222021
Cost of revenue$601 $494 $410 
Product development902,130 701,715 446,596 
Sales and marketing130,665 105,231 57,070 
General and administrative242,701 261,849 103,966 
     Total$1,276,097 $1,069,289 $608,042